Table 1 Characteristics of participants who enrolled in the study after receiving a COVID-19 diagnosis at a Baylor Scott & White Health facility between September 9, 2021 and November 12, 2021
Total | Unvaccinated | Vaccinated | ||
|---|---|---|---|---|
n = 149 | n = 40 | n = 109 | p-value | |
Age, mean ± sd | 52.0 ± 13.9 | 46.2 ± 12.9 | 54.1 ± 13.8 | 0.003 |
Female sex | 118 (80.3%) | 30 (78.9%) | 88 (80.7%) | 0.866 |
BMI (n = 145), mean ± sd | 31.7 ± 8.3 | 32.2 ± 8.5 | 31.5 ± 8.2 | 0.779 |
Categories | 0.984 | |||
Normal | 31 (21.4%) | 7 (18.9%) | 24 (22.2%) | |
Overweight | 35 (24.1%) | 9 (24.3%) | 26 (24.1%) | |
Obese | 79 (54.5%) | 21 (56.8%) | 58 (53.7%) | |
Race | 0.328 | |||
White | 119 (81%) | 31 (81.6%) | 88 (80.7%) | |
Black | 10 (6.8%) | 1 (2.6%) | 9 (8.3%) | |
Hispanic | 8 (5.4%) | 4 (10.5%) | 4 (3.7%) | |
Other/unknown | 10 (6.8%) | 2 (5.3%) | 8 (7.3%) | |
Married | 99 (67.3%) | 23 (60.5%) | 76 (69.7%) | 0.221 |
Education | < 0.001 | |||
Highschool or less | 17 (11.6%) | 11 (28.9%) | 6 (5.5%) | |
Some college or Vocational/technical/Associates degree | 52 (35.4%) | 16 (42.1%) | 36 (33%) | |
Bachelor’s degree | 43 (29.3%) | 6 (15.8%) | 37 (33.9%) | |
Advanced degree | 35 (23.8%) | 5 (13.2%) | 30 (27.5%) | |
Employed (n = 145) | 114 (76.5%) | 29 (76.3%) | 85 (78%) | 0.742 |
Income (n = 143) | 0.003 | |||
<$30,000 | 16 (11.2%) | 7 (18.9%) | 9 (8.5%) | |
$30,000 - $60,000 | 29 (20.3%) | 9 (24.3%) | 20 (18.9%) | |
$60,000 - $100,000 | 38 (26.6%) | 13 (35.1%) | 25 (23.6%) | |
$100 - $150,000 | 35 (24.5%) | 5 (13.5%) | 30 (28.3%) | |
>$150,000 | 25 (17.5%) | 3 (8.1%) | 22 (20.8%) | |
Current working status (n = 143) | 0.216 | |||
Working at my normal location | 51 (35.2%) | 11 (29.7%) | 40 (37%) | |
Working from home | 32 (21.8%) | 8 (21.6%) | 24 (22.2%) | |
Not working/Unemployed due to COVID-19 | 19 (13.1%) | 8 (21.6%) | 11 (10.2%) | |
Not working right now for other reasons | 43 (29.7%) | 10 (27%) | 33 (30.6%) | |
Any comorbidity 1 | 96 (65.3%) | 22 (57.9%) | 74 (67.9%) | 0.238 |
Current or past smoker | 36 (24.5%) | 8 (21.1%) | 28 (25.7%) | 0.690 |
Any current mental health diagnosis | 59 (39.9%) | 16 (42.1%) | 43 (39.4%) | 0.805 |
Any past mental health diagnosis | 50 (27.5%) | 12 (31.6%) | 38 (34.9%) | 0.661 |
Covid experience | ||||
Hospitalized | 11 (7.4%) | 9 (22.5%) | 2 (1.8%) | < 0.001 |
On ventilator | 1 (0.7%) | 1 (2.5%) | 0 (0%) | NA |
Stigma Scale T-score, mean ± sd | 54.4 ± 8.6 | 57.3 ± 10.6 | 53.4 ± 7.5 | 0.042 |
COVID Fear, mean ± sd | 16.5 ± 6.8 | 16.3 ± 7.6 | 16.6 ± 6.6 | 0.795 |
Vaccine received | - | |||
Pfizer | - | - | 57 (52.3%) | - |
Moderna | - | - | 42 (38.5%) | - |
Johnson & Johnson/Janssen | - | - | 8 (7.3%) | - |
Not specified | - | - | 2 (1.8%) | - |
If two-dose vaccine, completed | - | - | 95 (96%) | - |
If one-dose vaccine, time since dose (days), median (IQR) | - | - | 191.5 (173.5, 197.5) | - |
If two dose vaccine, time since second dose (days), median (IQR) | - | - | 192 (163.5, 216.5) | - |
Time since fully vaccinated (time since last dose – 14 days), median (IQR) | - | - | 178 (149.5, 198.0) | - |
Intention to be vaccinated in the future | ||||
Yes | - | 10 (25%) | - | - |
Maybe | - | 18 (45%) | - | - |
No | - | 12 (30%) | - | - |